Diane Ignar is an accomplished professional in the biotechnology and pharmaceutical sectors, currently serving as the Head of New Drug Development at the Chordoma Foundation and a Strategic Advisor at the Harrington Discovery Institute. With extensive experience as President of Surrey View Consulting, LLC, Diane provides consulting services focused on drug development and R&D strategy. Previous roles include SVP of Business Development at Eldec Pharmaceuticals, President and CSO at Ostrea Bio Inc, and Senior Director of Product Development at GlaxoSmithKline, where significant contributions were made in various therapeutic areas. Diane has actively participated on boards and advisory groups, including roles with the University of North Carolina and the Council for Entrepreneurial Development. Educational qualifications include a Ph.D. in Neuropharmacology from Duke University and a B.S. in Pharmacy from Purdue University.
This person is not in any teams
Harrington Discovery Institute at University Hospitals
The Harrington Discovery Institute at University Hospitals in Cleveland, OH – part of The Harrington Project for Discovery & Development – aims to advance medicine and society by enabling our nation’s most inventive scientists to turn their discoveries into medicines that improve human health. Harrington Discovery Institute was created in 2012 with a $50 million founding gift from the Harrington family and instantiates the commitment they share with University Hospitals to a Vision for a ‘Better World’.